MemoryXL Effects on Mild Cognitive Impairment Patients
Stopped Risk/benefit ratio did not indicate further study would be useful, or fair to future subjects.
Conditions
- Mild Cognitive Impairment
Interventions
- DRUG: Memory XL
- DRUG: placebo
Sponsor
University of Oklahoma